Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

We’ve seen the first AI-generated commercials, songs and even social media influencers outside of healthcare. Will pharma be ...

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

The June agreement (PDF) established a fixed revenue-sharing model, with TME Pharma receiving a “larger share of future ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...

Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the ...

For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.